Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for Gprotein coupled receptors (GPCRs)

Details for Australian Patent Application No. 2005261930 (hide)

Owner Zentaris GmbH

Inventors Schmidt, Peter; Polymeropoulos, Emmanuel; Paulini, Klaus; Soderhall, Arvid; Gerlach, Matthias; Kuhne, Ronald; Gunther, Eckhard; Baasner, Silke

Agent Spruson & Ferguson

Pub. Number AU-B-2005261930

PCT Pub. Number WO2006/005484

Priority 10 2004 033 902.3 14.07.04 DE; 60/587,969 14.07.04 US; 60/683,178 20.05.05 US

Filing date 5 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 11 December 2008

International Classifications

C07D 209/82 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/005484 Priority application(s): WO2006/005484

11 December 2008 Application Accepted

  Published as AU-B-2005261930

9 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261932-Sulfonamide derivatives

2005261923-Combination therapywith radiolabeled anti-CD20 antibody in the treatment of B-cell lymphoma